Clinical trial

Bioequivalence Study for Acarbose/Metformin FDC

NCT04065581

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-10-14

PhasePHASE1

Study timeline

Study start (actual)2019-10-14Date precision: day

Registry last updated2020-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Acarbose/Metformin FDC(BAY81-9783)DRUG

GlucobayDRUG

GlucophageDRUG · verified · RxNorm: Glucophage

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04065581 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.